Belgium· BE-AMP-SAM458435-00
Abacavir/Lamivudine/Zidovudine Mylan 300 mg - 150 mg - 300 mg
A zidovudine, lamivudine and abacavir product containing abacavir sulfate, registered in Belgium by Viatris GX. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Zidovudine, lamivudine and abacavir is registered in 10 of 19 countries.
Countries holding a registration under ATC J05AR04 (zidovudine, lamivudine and abacavir), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Zidovudine, lamivudine and abacavir · ATC J05AR04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Abacavir Sulfate
- Manufacturer
- Viatris GX
- Country
- Belgium (BE)
- ATC code
- J05AR04
- ATC class
- Zidovudine, lamivudine and abacavir
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for zidovudine, lamivudine and abacavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zidovudine, lamivudine and abacavir · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Zidovudine, lamivudine and abacavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAbacavirMajor Pharmaceuticals
- FranceABACAVIR ARROW 300 mg, comprimé pelliculé sécableARROW GENERIQUES
- SpainABACAVIR ACCORD 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FinlandAbacavir AccordAccord Healthcare B.V.
- NetherlandsAbacavir Accord 300 mg, filmomhulde tablettenAccord Healthcare B.V.
- PolandAbacavir AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAbacavir Accord 300 mg Filmdragerad tablettAccord Healthcare B.V.
- IcelandZiagenViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Spain · Abacavir Tarbis
- Finland · Abacavir Accord
- France · Abacavir Arrow, Abacavir Sandoz
- United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
- Iceland · Ziagen
- Italy · Abacavir Mylan
- Liechtenstein · Ziagen
- Netherlands · Abacavir Accord, Abacavir Sandoz
- Norway · Ziagen
- Portugal · Abacavir Farmoz, Abacavir Generis
- Romania · Abacavir Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/967d9f8d-30b5-4210-8a71-ab98b2c64ad4 GET /v1/drugs/967d9f8d-30b5-4210-8a71-ab98b2c64ad4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Abacavir/Lamivudine/Zidovudine Mylan 300 mg - 150 mg - 300 mg",
"name_fr": "Abacavir/Lamivudine/Zidovudine Mylan 300 mg - 150 mg - 300 mg",
"name_nl": "Abacavir/Lamivudine/Zidovudine Mylan 300 mg - 150 mg - 300 mg",
"amp_code": "SAM458435-00",
"strengths": [
"351.4000",
"300.0000",
"150.0000",
"300.0000"
],
"pack_count": 13,
"substances": [
"Abacavir Sulfate",
"Abacavir",
"Lamivudine",
"Zidovudine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Zidovudine, Lamivudine and Abacavir",
"authorisation_numbers": [
"BE458444",
"BE458453"
]
}See everything about zidovudine, lamivudine and abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.